[go: up one dir, main page]

ITPD950089A0 - Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci - Google Patents

Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci

Info

Publication number
ITPD950089A0
ITPD950089A0 ITPD950089A ITPD950089A ITPD950089A0 IT PD950089 A0 ITPD950089 A0 IT PD950089A0 IT PD950089 A ITPD950089 A IT PD950089A IT PD950089 A ITPD950089 A IT PD950089A IT PD950089 A0 ITPD950089 A0 IT PD950089A0
Authority
IT
Italy
Prior art keywords
matri
drugs
preparation
hyaluronic acid
controlled release
Prior art date
Application number
ITPD950089A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT95PD000089A priority Critical patent/IT1281876B1/it
Publication of ITPD950089A0 publication Critical patent/ITPD950089A0/it
Priority to AU58945/96A priority patent/AU5894596A/en
Priority to PCT/EP1996/001980 priority patent/WO1996035721A1/en
Publication of ITPD950089A1 publication Critical patent/ITPD950089A1/it
Application granted granted Critical
Publication of IT1281876B1 publication Critical patent/IT1281876B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
IT95PD000089A 1995-05-10 1995-05-10 Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. IT1281876B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT95PD000089A IT1281876B1 (it) 1995-05-10 1995-05-10 Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.
AU58945/96A AU5894596A (en) 1995-05-10 1996-05-08 A dicarboxylic acid hemiester or hemiamide with a pharmacolo gically active compound and with hyaluronic acid or with a h yaluronic acid ester, a process for its preparation and a co ntrolled release medicament containing this derivative
PCT/EP1996/001980 WO1996035721A1 (en) 1995-05-10 1996-05-08 A dicarboxylic acid hemiester or hemiamide with a pharmacologically active compound and with hyaluronic acid or with a hyaluronic acid ester, a process for its preparation and a controlled release medicament containing this derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95PD000089A IT1281876B1 (it) 1995-05-10 1995-05-10 Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.

Publications (3)

Publication Number Publication Date
ITPD950089A0 true ITPD950089A0 (it) 1995-05-10
ITPD950089A1 ITPD950089A1 (it) 1996-11-10
IT1281876B1 IT1281876B1 (it) 1998-03-03

Family

ID=11391039

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95PD000089A IT1281876B1 (it) 1995-05-10 1995-05-10 Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.

Country Status (3)

Country Link
AU (1) AU5894596A (it)
IT (1) IT1281876B1 (it)
WO (1) WO1996035721A1 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
KR20010025040A (ko) * 1998-05-20 2001-03-26 나가야마 오사무 관절질환 치료제 및 히알루론산의 결합체
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
WO2005066214A1 (ja) * 2004-01-07 2005-07-21 Seikagaku Corporation ヒアルロン酸誘導体及びそれを含む薬剤
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
IE20060049A1 (en) * 2006-01-25 2007-08-08 Eurand Pharmaceuticals Ltd A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents
IE20070900A1 (en) * 2007-12-12 2009-06-24 Eurand Pharmaceuticals Ltd New anticancer conjugates
IT1391251B1 (it) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl Composizione per il trattamento delle patologie articolari
JP5542687B2 (ja) * 2008-11-05 2014-07-09 国立大学法人 東京医科歯科大学 ヒアルロン酸誘導体、およびその医薬組成物
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
CN104603156B (zh) * 2012-09-05 2016-10-26 中外制药株式会社 引入有氨基酸和甾基的透明质酸衍生物
WO2015005458A1 (ja) * 2013-07-10 2015-01-15 生化学工業株式会社 グリコサミノグリカン誘導体及びその製造方法
US10675354B2 (en) 2013-07-10 2020-06-09 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
GB2518405A (en) * 2013-09-20 2015-03-25 Zeiss Carl Meditec Ag Composition comprising at least one viscoelastic polymer
SI3226905T1 (sl) 2014-02-27 2022-04-29 Synartro Ab Konjugati hialuronana s farmacevtskimi učinkovinami, postopki in sestavki
JP7641129B2 (ja) 2020-02-05 2025-03-06 旭化成株式会社 ヒアルロン酸誘導体組成物、医薬組成物及びヒアルロン酸誘導体-薬物結合体組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2604930B2 (ja) * 1990-12-14 1997-04-30 株式会社ディ・ディ・エス研究所 ヒアルロン酸およびコンドロイチン誘導体
EP0540751A4 (en) * 1991-05-20 1994-10-26 Eisai Co Ltd Steroid compound combined with polysaccharide
JPH0616702A (ja) * 1992-04-21 1994-01-25 Shiseido Co Ltd 修飾ヒアルロン酸、その製造方法及びそれを用いた徐放化製剤

Also Published As

Publication number Publication date
ITPD950089A1 (it) 1996-11-10
AU5894596A (en) 1996-11-29
WO1996035721A1 (en) 1996-11-14
IT1281876B1 (it) 1998-03-03

Similar Documents

Publication Publication Date Title
ITPD950089A0 (it) Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci
FI944275L (fi) Menetelmä syklisten estereiden valmistamiseksi hydroksihapoista ja niiden johdannaisista
MX9205168A (es) Derivados de esteres azabiciclicos fusionados y procedimiento para su preparacion.
MX9206236A (es) Composiciones farmaceuticas de liberacion controlada y proceso para su preparacion.
ITMI922006A0 (it) Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preprazione
FI945476L (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
ITPD920071A0 (it) Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
FI945776L (fi) Yhden astian menetelmä 3-kinolonikarboksyylihaapojohdannaisten valmistamiseksi
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
MX9205916A (es) Derivados de acido ciclohexanoacetico, proceso para su preparacion y composicion farmaceutica que los comprende
PT956010E (pt) Micro-esferas farmaceuticas de acido valproico para administracao oral
ITMI962406A0 (it) Procedimento per la preparazione di derivati cefalosporanici
PT801561E (pt) Composicao e metodos para a entrega transdermica de drogas labeis a acido
FI972949A0 (fi) Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä
ITPD910160A0 (it) Esteri di derivati carbossilici di polisaccaridi
IT1241128B (it) Procedimento per la preparazione di derivati chinazolinici
PT876367E (pt) Derivados de esteres do acido trans-apovincaminico utilizados como farmacos
ITMI920560A1 (it) Procedimento per la preparazione di acido iodesossicolico ad elevata purezza per impiego farmaceutico
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
IT1284090B1 (it) Procedimento per la preparazione di cefem derivati
PL301415A1 (en) Novel derivatives of phenyloacetic acid, method of obtaining such derivative, pharmaceutical and method of obtaining /2-(2,6-dichloroanilline)phenylo/-acetoxyacetic acid
ITPD940069A0 (it) Derivati viscoelastici di acido ialuronico
ITMI950780A0 (it) Estere chinolonico di derivati dell'acido 3-cefem-4-carbossilico
ITMI921125A1 (it) Procedimento per la preparazione di derivati beta-lattamici alogenati
ITMI951297A0 (it) Processo per la preparazione di derivati dell'acido-metil-2- tiofeneacetico

Legal Events

Date Code Title Description
0001 Granted